- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 205/12 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 205/12
Total number of patents in this class: 141
10-year publication summary
2
|
4
|
9
|
13
|
11
|
14
|
13
|
19
|
14
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Constellation Pharmaceuticals, Inc. | 212 |
7 |
Inflazome Limited | 85 |
6 |
Janssen Pharmaceutica N.V. | 3399 |
4 |
Syngenta Crop Protection AG | 6052 |
4 |
Psy Therapeutics, Inc. | 14 |
4 |
Hoffmann-La Roche Inc. | 3405 |
3 |
Canopy Growth Corporation | 219 |
3 |
Celgene Corporation | 1412 |
3 |
ChemoCentryx, Inc. | 386 |
3 |
Cytokinetics, Inc. | 273 |
3 |
KBP Biosciences Co., Ltd. | 29 |
3 |
Taisho Pharmaceutical Co., Ltd. | 870 |
3 |
Toyama Chemical Co., Ltd. | 102 |
3 |
University of Virginia Patent Foundation | 1567 |
3 |
Aligos Therapeutics, Inc. | 150 |
3 |
F. Hoffmann-La Roche AG | 7929 |
2 |
Korea Advanced Institute of Science and Technology | 4364 |
2 |
Denali Therapeutics Inc. | 243 |
2 |
Institute for Basic Science | 350 |
2 |
Mitsubishi Tanabe Pharma Corporation | 579 |
2 |
Other owners | 76 |